A MODEL FOR PREDICTION OF PROBABILITY OF DEVELOPING AN ADVERSE PHYSIOLOGICAL SYMPTOM IN INDIVIDUALS PERCUTANEOUSLY EXPOSED TO VX NERVE AGENT